VEGF-A production in tumors has been linked to CD4+ FOXP3+ Treg cell abundance (Hansen et al., 2012, Terme et al., 2013) and decreased infiltration by tumor-reactive CD8+ T cells (Peng et al., 2016). Here, FOXP3 is linked to neoplasm.